Cardiomyopathy Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults who are able to understand and agree to participate on their own behalf
- Children whose parent or guardian is able to give consent on their behalf
- People of any gender (male or female)
- People who have been formally diagnosed with cardiomyopathy (a condition affecting the heart muscle) or a related condition
- People who have a family member diagnosed with cardiomyopathy or a related condition
- People who have been found to carry a gene variant that may increase the chance of developing cardiomyopathy or a related condition
Who may not be able to join:
- People who do not have the ability to understand and agree to participate, and who do not have a parent or guardian available to consent on their behalf
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: James Ware, Imperial College London
Phone: 02073528121
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Incidence of genetic variants; The incidence of major adverse cardiovascular events over 5 years
Can't join this trial?
Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.